1246415

Emily A. DiMango, M.D. — FEI 3013753808

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 13, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
2272721 CFR 312.64(b)Safety Reports - Serious Events